Premier Healthcare Alliance awarded several new contracts for drug-eluting stents, traditional stents and other intervention products to 8 heavy hitters in the cardiology space.
Abbott (NYSE:ABT), Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT) all landed supplier deals for drug-eluting and traditional stents.
Premier inked deals for other cardiac products, including diagnostic and interventional devices, with St. Jude Medical (NYSE:STJ), Johnson & Johnson (NYSE:JNJ), Merit Medical Systems (NSDQ:MMSI), Teleflex (NYSE:TFX) subsidiary Arrow International and Health Care Systems Inc.
The contracts kicked off last month and extend to Premier’s network of 2,800 hospitals in the U.S., according a statement from the GPO, which bills itself as the largest in the U.S.
